UK markets open in 6 hours 12 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.20 +0.25 (+0.32%) GOLD FUTURES
2,310.60 +1.00 (+0.04%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,098.64 +1,053.95 (+2.29%)
EMVision Medical Devices Ltd (EMV.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 10:20AM AEST. Market open.
| Previous close | 2.1500 |
| Open | 2.1200 |
| Bid | 2.0800 x 18400 |
| Ask | 2.1200 x 299700 |
| Day's range | 2.1000 - 2.1200 |
| 52-week range | 1.1300 - 2.7200 |
| Volume | |
| Avg. volume | 64,318 |
| Market cap | 179.392M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireEMVision Sets Sight on US With US$10M Keysight Investment
SYDNEY, February 28, 2024--EMVision, an Australian medical device company focused on developing innovative portable brain imaging technology, has announced a US$10 million (~A$15.28m) strategic investment from Keysight Technologies, a global leader in test and measurement technology.
Simply Wall St.EMVision Medical Devices (ASX:EMV) shareholders have earned a 35% CAGR over the last five years
For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly...
- Simply Wall St.
EMVision Medical Devices Full Year 2023 Earnings: AU$0.05 loss per share (vs AU$0.081 loss in FY 2022)
EMVision Medical Devices ( ASX:EMV ) Full Year 2023 Results Key Financial Results Revenue: AU$7.09m (up 63% from FY...
© 2024 Yahoo. All rights reserved.